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Tie2, coded by the TEK gene, is a tyrosine kinase receptor and plays a central role in vascular
stability. It was suggested that variations in the TEK genemight influence the susceptibility to asthma
andallergic conjunctivitis. The aimof this studywas to further investigate these suggestions, involving
different populations and to study the Tie2 related pathway on a mouse model of asthma. The
discovery, stage I cohort involved 306 patients withmoderate and severe allergic rhinitis, the stage II
study consisted of four cohorts, namely, adult and pediatric asthmatics and corresponding controls.
Altogether, there were 1,258 unrelated individuals in these cohorts, out of which 63.9% were
children and36.1%were adults. In stage I, 112SNPswere screened in theTEKgeneof thepatients
in order to search for associations with asthma and allergic conjunctivitis. The top associated SNPs
were selected for association studies on the replication cohorts. The rs3824410SNPwas nominally
associated with a reduced risk of asthma in the stage I cohort and with severe asthma within the
asthmatic population (p=0.009;OR=0.48) in the replication cohort. In the stage I study, 5SNPswere
selected in conjunctivitis. Due to the low number of adult patients with conjunctivitis, only children
were involved in stage II. Within the asthmatic children, the rs622232 SNP was associated with
conjunctivitis in boys in the dominant model (p=0.004; OR=4.76), while the rs7034505 showed
association to conjunctivitis in girls (p=0.012; OR=2.42). In the lung of a mouse model of asthma,
expression changes of 10 Tie2 pathway-related geneswere evaluated at three points in time. Eighty
percent of the selected genes showed significant changes in their expressions at least at one time
point during the process, leading from sensitization to allergic airway inflammation. The expressions
of both the Tek gene and its ligands showed a reduced level at all time points. In conclusion, our
results provide additional proof that the Tie2 pathway, the TEK gene and its variations might have a
role in asthma and allergic conjunctivitis. The gene and its associated pathways can be potential
therapeutic targets in both diseases.
Keywords: asthma, conjunctivitis, Tie2 pathway, TEK gene, angiopoietin (Ang)February 2020 | Volume 11 | Article 1281
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Tie2 is a tyrosine-protein kinase receptor located principally on
vascular endothelial cells and plays a crucial role in the stability
of the vascular system (Zhang et al., 2019). In human there are
three known Tie2 ligands, angiopoietin 1 (Ang1), Ang2, and
Ang4 with similar affinity for binding to Tie2. The best-studied
member, Ang1 stimulates the activity of the kinase by binding to
Tie2. The role of Ang2 is rather controversial, it can function as
an Ang1 antagonist, although, in some cases, it may act as a
partial agonist. Under certain conditions, Ang2 can also promote
angiogenesis. Ang4 can modulate Ang1 signaling and also has an
antimicrobial effect. Tie2 signaling pathway appears to
complement the VEGF pathway by contributing to subsequent
stages of vascular development (Brindle et al., 2006; Augustin
et al., 2009; Thurston and Daly, 2012).
Ang1 can support endothelial cell survival through the stimulation
of the PI3K-Akt1 pathway, and comparable results could be achieved
with elevated concentrations of Ang2. Signaling by the PI3K-Akt1
pathway contributes to eNOS phosphorylation, NO production, and
angiogenesis (Figure 1) (Karar and Maity, 2011).Frontiers in Genetics | www.frontiersin.org 2The Tie2 receptor is encoded by the TEK (TEK Receptor
Tyrosine Kinase) gene in humans. TEK is abundantly expressed
in the lung and in the endothelium of Schlemm’s canal in the eye
and the Tie2 pathway has been suggested that it might play a role
in asthma and different eye disorders including allergic
conjunctivitis (Souma et al., 2016; Fodor et al., 2018).
Asthma is a chronic pulmonary disease affected by a large
amount of environmental and genetic factors. Both
neovascularization and angiogenesis are also remarkable
features of asthma causing structural changes in the airway
walls. Increased vascularity and angiogenesis in asthmatic
patients contribute to airway occlusion as a result of an
increase in airway wall thickness (Temesi et al., 2014; Fodor
et al., 2017).
Severe asthma is a subtype of difficult-to-treat asthma which
occurs in 5–10% of the asthmatic population. Severe asthma is
considered if the patient remains uncontrolled despite optimal
treatment. Although, it is only a few percent within the asthmatic
population, the care of these patients accounts for more than
60% of the total financial expenditure on asthma (Al-Hajjaj,
2011; Hekking et al., 2015; Highley et al., 2019).FIGURE 1 | Tie2 related pathways (Karar and Maity, 2011). Ten genes were selected from these pathways for the gene expression analyses in the mouse model of
asthma: Angpt1; Angpt2; Angpt4; Tek; Nfkb1; Kdr (gene for Vegfr2); Pik3ca; Akt1; Nos3; Ptprb. (The figure was created with BioRender.)February 2020 | Volume 11 | Article 128
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American populations of European origin, the strongest signals
were identified at the 9p21.2 locus spanning three genes (EQTN,
MOB3B, TEK) and consisting of four single nucleotide
polymorphisms (SNPs) in strong linkage disequilibrium (LD)
with each other. Based on its function, it has been hypothesized
that variations in the TEK gene were responsible for the
association with asthma (Almoguera et al., 2017).
It is well-known that allergic asthma often occurs together
with other atopic diseases. Allergic rhinitis and conjunctivitis are
the most frequent asthma-associated atopic comorbidities.
According to different studies, 50–65% of patients with rhinitis
also had conjunctivitis, although conjunctivitis could also exist
without rhinitis. Conjunctivitis is an inflammation of the eye
characterized by itching, flushing, swelling and the watering of
the eyes. Although allergic diseases have genetic backgrounds,
there is very little information about allergic conjunctivitis from
that point of view (Rosario and Bielory, 2011; Shaker and
Salcone, 2016; Fodor et al., 2018). Despite the fact that
different kinds of anti-al lergic medication used in
ophthalmology, patients with allergic conjunctivitis are
generally undertreated. According to a French survey, more
than 20% of the patients with allergic conjunctivitis have
persistent symptoms despite the treatment. Furthermore,
symptoms are underestimated because the huge negative effect
on the quality of life is frequently ignored and it is misdiagnosed
or under-diagnosed due to other disorders of the eye (Klossek
et al., 2012). These imply that novel therapeutic targets are
needed in both severe asthma and conjunctivitis.
Earlier, we investigated in a pediatric European population
whether three expression QTL SNPs in the TEK gene influenced
the susceptibility to asthma or associated phenotypes. We did not
find any significant connection between these SNPs and asthma,
however, one of the variations showed a rather strong association
with allergic conjunctivitis (Fodor et al., 2018).
In the present study, we aimed to further investigate the
possible role of the TEK gene in asthma and allergic
conjunctivitis involving novel populations. We screened an
allergic population (discovery cohort) with 112 SNPs in the
TEK gene and searched for associations with asthma and allergic
conjunctivitis. We selected the top associated SNPs and carried
out association studies on different populations (replication
cohorts). We also studied the Tie2 related pathways on a
mouse model of asthma.MATERIALS AND METHODS
Study Populations
We performed our study in two stages. The discovery cohort
comprised participants from the DesensIT project which is
described in a paper of Molnár et al. (2017). Participants were
selected from patients of five Hungarian allergic outpatient
centers with documented ragweed allergy and/or with clinical
history for at least 2 years with peak symptoms in August–
September and agreed to participate in the study. Those patientsFrontiers in Genetics | www.frontiersin.org 3were preferred who had moderate-severe seasonal allergic
rhinitis based on Allergic Rhinitis and its Impact on Asthma
(ARIA) criteria and whose respiratory symptoms remain
troublesome despite avoidance or adequate pharmacologic
therapy and interfering with usual daily activities or with sleep
during the ragweed pollen season. Only adult and adolescent
patients at the age of 14–65 years were included in this
population. The patients completed questionnaires, including
RQLQ (Rhinoconjunctivitis Quality of Life Questionnaire) and
RTSS (rhinoconjunctivitis total symptom score), then lung
function tests, physical examination and discussion of the
allergy-related status were carried out. A diagnosis of ragweed
allergy was made in subjects with positive results of allergen-
specific serum IgE and skin prick tests (SPTs) in presence of a
positive clinical history for allergic respiratory symptoms with a
peak in the August–September months. As these patients during
the DesensIT project were treated between 2012 and 2014 with
sublingual immunotherapy against ragweed allergy, the allergic
subphenotypes which are presented in Table 1 were determined
before the immunotherapy was started. The conjunctivitis was
diagnosed by physicians according to the RQLQ and RTSS
subscale, drug-usage and physical investigation.
The stage II cohorts consisted of 4 cohorts, namely adult and
pediatric asthmatics and the corresponding controls. Altogether,
they included 1,258 unrelated individuals, out of which 63.9%
were children and 36.1% were adults. In the children population,
264 asthmatic samples were collected from different centers in
Hungary. Out of the 454 adult samples, 237 were derived from
asthmatic patients from the Asthma ambulance of the National
Korányi Institute of TB and Pulmonology and the Department of
Pulmonology of Semmelweis University. Asthma was diagnosed
according to GINA (Global Initiative for Asthma) guidelines, as
described earlier (Ungvári et al., 2012b; Ungvári et al., 2012a;
Ungvári et al., 2012c). Patients with severe asthma (GINA 4-5)
are described in more detail in a recent paper (van Bragt et al.,
2019). Allergic conjunctivitis was found in 101 asthmatic
patients. The diagnosis of allergic conjunctivitis was made by
physician. Due to the low number of adult asthmatics with
conjunctivitis, in the case of conjunctivitis, only children were
involved in the statistical analysis. FEV1 (forced expiratory
volume in 1 second) values were used to estimate the lung
function of the asthmatic patients. Allergy status wasTABLE 1 | Characteristics of the stage I discovery cohort.
Demographic and clinical characteristics All
Total (n) 306
Male (n) (%) 136 (44.5)
Female (n) (%) 170 (55.5)
Age (mean (SD) year) 39.2 (12.3)
Comorbidities Rhinitis (n (%)) 306 (100)
Asthma (n (%)) 68 (22.1)
Conjunctivitis (n (%)) 232 (75.8)
Atopic dermatitis (n (%)) 23 (7.5)
Food allergy (n (%)) 24 (7.8)February 2020 | Volume 11 | Article 128
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skin prick test. All participants were Hungarian (Caucasian), out
of which about 5% were of Gypsy origin based on the Hungarian
statistical database. Information of the study population can be
found in Table 2.
The samples of control children were from the Orthopaedic
Department of Budai Children’s Hospital and the Urological
Department of Heim Pál Children’s Hospital. The controls
showed no symptoms of asthma or allergy, nor any need for
medication. The adult controls were all healthy blood donors
(Table 2).
Written informed consent was provided by all patients or
their parent/guardian. A detailed description of patients can be
found in Tables 1 and 2. The study was carried out according to
the Declaration of Helsinki and was approved by the Ethics
Committee of the Hungarian Medical Research Council.
Genotyping
Genomic DNA was isolated from whole blood samples of 1,564
individuals using the QIAamp DNA Blood Midi kit (Qiagen,
Maryland, USA) or the iPrep PureLink gDNA Blood kit with
iPrep Purification Instrument (Invitrogen, Carslbad, CA, USA).
Participants of the DesensIT project (Molnár et al., 2017)
were genotyped by the Genome-Wide Human SNP Array 6.0
(Applied Biosystems, Foster City, CA, USA). In the present
study, only 112 SNPs in the TEK gene were evaluated. All
genotyped SNPs with >80% call rate located in the genomic
region ± 6 kb of the TEK gene were selected and filtered
according to the Hardy-Weinberg equilibrium criteria (p-value
of chi-square goodness-of-fit test > 0.01) and minimal allele
frequency threshold (>0.02). From the initial number of 112Frontiers in Genetics | www.frontiersin.org 4genotyped SNPs, 104 SNPs fulfilled all selection criteria. SNP
imputation was not performed.
The KBiosciences Competitive Allele-Specific PCR (KASP)
version 4.0 genotyping system was utilized (LGC Genomics,
Berlin, Germany) along with the ABI 7900HT Fast Real-Time
PCR system (Applied Biosystems, Foster City, CA, USA) to
genotype the rs3739542, rs994934, rs622232, rs638203,
rs7034505 SNPs. The sixth SNP (rs3824410) was genotyped
with TaqMan SNP Genotyping Assay and Master Mix
(Applied Biosystems). The TaqMan genotyping system is based
on the same method but a different design as the KASP system.Gene Expression Measurement in a
Mouse Model of Asthma
The animal model and the gene expression measurements are
described in detail in an earlier paper (Tölgyesi et al., 2009).
Briefly, in this experiment 6- to 8-week-old, female, pathogen-
free BALB/c mice were used. Three groups of mice (6 mice/
group) were sensitized by intraperitoneal injection of 20 mg
Ovalbumin (OVA) emulsified in 2.25 mg aluminium hydroxide
(Imject Alum) in a total volume of 100 mL phosphate-buffered
saline (PBS) on days 0 and 14. Non-sensitized animals (controls)
received Alum combinated with PBS only. On days 28, 29, and
30, mice were challenged with 1% OVA aerosol (in PBS) or PBS
only (controls) for 20 min by an ultrasonic nebulizer (Omron,
Budapest, Hungary) in a plastic chamber. Measurements of lung
resistance were carried out on day 31, 24 h after the last
challenge. On days 28 and 30, 4 h after the first and third
allergen challenge, respectively, mice in groups 1 and 2 were
anaesthetized by an intraperitoneal injection of ketamine and
xylazine and the lungs were removed for additional analysis. On
day 31, 24 h after the third (last) allergen challenge mice in group 3
and the controls were anaesthetized and airway hyperresponsiveness
(AHR) was assessed and then bronchoalveolar lavage fluid (BALF)
sampling and lung tissue collections were performed, the identical
way as it was performed in groups 1 and 2.
RNA from mouse lung was isolated by RNeasy columns
(Qiagen, Valencia, CA, USA). Agilent Whole Mouse Genome
Oligo Microarray 4x44K chips were used to analyze gene
expression patterns in the lung. The results were deposited in the
GEO database with a record number of GSE11911. (GSE11911 -
GEO DataSets - NCBI).Statistics
Hardy-Weinberg equilibrium (HWE) was tested using the chi-
square goodness-of-fit test implemented in the online DeFinetti
HWE application (Helmholtz Zentrum München, Institut für
Humangenetik, http://ihg.gsf.de/cgi-bin/hw/hwa1.pl) with a
significance level of 0.01. SNP data were analyzed using SPSS
version 19 (SPSS Inc., Chicago, IL, USA) software. Logistic
regression analyses were used to evaluate the association
between TEK genotypes and asthma or allergic conjunctivitis.
In all multivariate logistic regression analyses, age and gender


















Age ± SD 10.6 ± 3.8 50 ± 16.1 8.7 ± 4.0 30.4 ±
12.5




93 (35)/171 8 (10)/71


















Under 80% 0 161
Above 80% 11 74GINA, Global Initiative for Asthma; FEV1, forced expiratory volume in 1 sec.February 2020 | Volume 11 | Article 128
Gál et al. TEK Gene, Asthma and ConjunctivitisLinkage disequilibrium calculations and haplotype analyses
were carried out by Haploview version 4.2 software (Broad
Institute, Cambridge, Maine, USA). Single locus and multi-
marker haplotype association tests were performed with
Pearson’s chi-squared test.
All SNPs that nominally significantly associated with asthma
or allergic conjunctivitis in the discovery cohort were selected for
further investigation in the stage II cohorts.
Microarray raw data were processed by the Feature Extraction
software version 7.5 with default parameter settings for two-color
oligonucleotide microarrays and then transferred to GeneSpring
9.02 program (Agilent Technologies, Palo Alto, CA, USA) for
further processing. In GeneSpring, the normalization and data
transformation steps recommended by Agilent Technologies for
two-color data were applied. Statistical analysis was performed
using the R statistical software (version 3.5.1) (R Core Team,
2018). T-test was applied to identify genes that were differentially
expressed between the respective groups against the common
reference control. Log2 transformed fold changes (logFC)
between the respective groups and the common reference were
calculated for 10 selected genes, namely for Angpt1; Angpt2;
Angpt4; Tek; Nfkb1; Kdr (gene for Vegfr2); Pik3ca; Akt1; Nos3;
Ptprb (gene for Ve-tpt). The false discovery rate (FDR) multiple
testing correction method according to Benjamini and Hochberg
was applied with p < 0.05 cutoff in our statistical tests.RESULTS
Stage I SNP Association Studies in
Patients With Ragweed Allergy
In our stage I study, we utilized the results of a genome-wide SNP
genotyping in a population with documented ragweed allergy
with moderate-severe rhinitis (Molnár et al., 2017). Some
characteristics of this group are shown in Table 1. Here, we
evaluated the genotyping results of 112 SNPs in the TEK gene.
The genotyping and the HWE results, the call rates and
information about the SNPs are presented in Supplementary
Table 1. All the genotype distributions of the SNPs corresponded
to the HWE. In our evaluations, we considered only SNPs with a
call rate above 80% and a minimal allele frequency > 0.02. In this
way, altogether 104 SNPs in the TEK gene were evaluated.
In this group, 75.8% of the patients had conjunctivitis and
22.1% asthma. First, we compared the allele and genotype
distributions between patients with and without conjunctivitis.
The results of the statistical evaluations of the comparisons of
allelic frequencies are presented in Supplementary Table 2
(sheet: singlemarker). In the comparison of allelic frequencies
between ragweed allergic patients with and without
conjunctivitis, altogether 6 SNPs reached the uncorrected
significance level (p < 0.05). The lowest p-value was 0.0048 in
the case of rs7034505.
Based on the genotyping results, the linkage disequilibrium
map of the TEK gene was calculated (Supplementary Figure 1).
Altogether, 17 haplotypes were identified and their possible
associations with conjunctivitis were investigated. The resultsFrontiers in Genetics | www.frontiersin.org 5of the statistical evaluation are presented in Supplementary
Table 2 (sheet: haplotypeblocks). No haplotype showed
association with conjunctivitis.
The genotypic tests were carried out using recessive (R; 22 vs
12 + 11 genotypes, where two stands for the risk allele),
dominant (D; 22 + 12 vs 11) and additive (A; 11 vs 12 vs 22)
models. The results of these tests are shown in Supplementary
Table 3. In this case, 15 models reached the uncorrected
significance level and the strongest association was found for
rs638203 in the recessive model (p= 0.006; OR = 7.8 (95% CI:
1.80–33.77)).
According to the results, five SNPs (rs3739542; rs994934;
rs622232; rs638203; rs7034505) were selected for further
investigations in additional populations.
The same tests were carried out for asthma. The results are
shown in Supplementary Table 4. In this case, one SNP
(rs3824410) reached the uncorrected significance level in three
different models, namely in additive (p = 0.0077; OR = 0.49 (95%
CI: 0.29–0.83)), dominant (p= 0.02; OR = 0.51 (95% CI: 0.29–
0.90)) and also the allelic frequencies were significantly different
between the asthmatic and non-asthmatic populations (p =
0.008; OR = 0.51 (95% CI: 0.30–0.84)). According to these
results, the rare (T) allele of this SNP in this allergic
population might reduce the risk of asthma. This SNP was also
selected for further association analysis in stage II study.
Stage II SNP Association Studies in
Adult and Pediatric Asthmatic and
Control Patients
The selected six SNPs were genotyped in populations, as
presented in Table 2. The results of the genotyping are shown
in Supplementary Table 5. First, we tested whether the selected
SNPs were associated with asthma in each age group or with
conjunctivitis in children because there were only eight adult
asthmatic patients with this symptom thus, they were excluded
from this analysis. As can be seen in Supplementary Table 5, no
allele associated directly with these diseases.
When we investigated the asthmatic children only, the minor
allele of the rs622232 SNP was associated with conjunctivitis (p =
0.027; OR = 1.65 (95%CI: 1.06-2.57)). When we examined the
two genders separately, however, the rs622232 SNP was
associated with conjunctivitis only in boys in both allelic and
dominant ways (p=0.004; OR =4.76 (95%CI: 1.54–14.75)), while
the minor allele of the SNP rs7034505 was associated with
conjunctivitis only in girls (p=0.012; OR=2.42 (95%CI: 1.20–
4.90)). The minor allele homozygotes of this SNP showed an
increased risk with a high odds ratio to conjunctivitis in girls
comparing it to the major allele homozygotes (p=0.019; OR=5.46
(95%CI: 1.24–24.09)) (Table 3).
Within the adult asthmatic group, the rare allele of rs3824410
was negatively associated with severe asthma (p=0.009; OR=0.48
(95% CI: 0.27–0.84)) and similar association was found in the
dominant model (p=0.022; OR = 0.45 (95%CI: 0.22–0.90)).
When only the adult allergic asthmatic patients were
considered, the minor T allele of the rs3824410 SNP also
associated with a lower risk of severe asthma (p=0.026;February 2020 | Volume 11 | Article 128
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Frontiers in Genetics | www.frontiersin.org 6OR=0.39; (95%CI: 0.17–0.91) and p=0.03; OR=0.33; (95%CI:
0.12–0.91)) on the allelic level and in the dominant model,
respectively. The above detailed results are summarized in
Table 4.
We computed linkage disequilibrium between the six selected
SNPs, and these showed no LD (the maximal r-square value was
0.11 between any pairs of SNPs). Therefore, we did not perform a
haplotype analysis of these SNPs.Investigation of the Possible Role of the
Angiopoietin-Tie2 Pathway in a Mouse
Model of Asthma
The detailed description of the lung characteristics of mice in the
different groups can be seen in an earlier paper (Tölgyesi et al.,
2009). Briefly, after intraperitoneal sensitization with OVA on
days 0 and 14, the first airway inhalation of allergen on day 28 led
to a remarkable neutrophil and macrophage recruitment in
BALF samples of the OVA-sensitized mice (group 1). This
initial neutrophil inflammation weakened during the
progression and almost entirely vanished by the end of the
protocol (group 3) while the asthma-related Th2-type
eosinophilic airway inflammation and hyperresponsiveness
evolved. On day 31 in mice of group 3, the lung resistance
measurements revealed strong AHR provoked by methacholine
in the OVA-challenged mice compared to controls,
demonstrating the development of AHR in mice undergoing
OVA sensitization and challenge.
Microarray analysis of the lung showed a marked alteration in
the gene expression profile during the asthmatic response. Out of
the 44 thousand transcripts 533, 1,554, and 1,134 transcripts
showed more than 2.0-fold statistically significant differential
expression in groups 1, 2, and 3 relative to the controls,
respectively (Tölgyesi et al., 2009). To investigate the possible
role of the Angiopoietin-Tie2 pathway in this model the relative
expressions of 10 genes from this pathway were studied
(Figure 1). The genes which were selected from the scientific
literatures were the followings: Angpt1; Angpt2; Angpt4; Tek;
Nfkb1; Kdr (gene for Vegfr2); Pik3ca; Akt1; Nos3; Ptprb (gene for
Ve-tpt). The expression levels of the two neighboring genes of
the TEK gene (Mob3b and Eqtn) were also measured. The logFC
values of the gene expressions and the statistical evaluations are
presented in Supplementary Table 6. Notably, out of the 10
genes, 8 showed significant changes in gene expressions during
the process. In Figure 2, the logFC values of the genes which
showed at least one significant change in the gene expressions
during the process are depicted. As can be seen, the expression
levels of most of the selected genes were reduced during the
process leading to AHR and eosinophil infiltration in the lung,
including Tek and Angpt1. The expression level of the Tek gene
reduced statistically significantly in group 2, and it remained
lower (although in this case, it was statistically not significant),
also in group 3. The expressions of the angiopoietin I gene were
significantly lower in all groups. In contrast, the expression of the
proinflammatory Nfkb1 whose expression is negatively regulated
by Tie2 and Ang1 was significantly elevated at all points in time.
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Frontiers in Genetics | www.frontiersin.org 7increase (Supplementary Table 6). No other differences were
found in case of Mob3b and Eqtn.”DISCUSSION
In the present study, we investigated whether genetic variations
in the TEK gene influence the susceptibility to asthma or allergic
conjunctivitis in multiple populations. We also studied the
possible role of Tie2 related pathways on a mouse model
of asthma.
The role of variations in the TEK gene in human asthma was
first suggested by a meta-analysis of genome-wide association
studies, that identified four SNPs on chromosome 9p21.2
associated with asthma in a European American population.
Although the detected SNPs were quite far from the TEK gene,
they were in linkage disequilibrium with a missense variant in
the TEK gene. However, no expression QTL (eQTL) effects were
shown in any of the tissues relevant to asthma during the fine
mapping of the region (Almoguera et al., 2017). Later, an
association study investigating three eQTL SNPs in the TEK
gene with known respiratory disease association found no
connection with asthma (Fodor et al., 2018). In the present
study, 112 SNPs were screened in the TEK gene and the selected
SNPs were investigated in other cohorts. The rs3824410 SNP was
found to be associated with asthma in a population with
moderate and severe rhinitis and with severe asthma in
another population involving asthmatic patients. In all cases,
the rare allele (T) of the rs3824410 SNP was associated with
lower susceptibility to asthma or to severe asthma with similar
odds ratios. These findings are in agreement with the previous
suggestion that variations in the TEK gene might play a role in
asthma in populations of European origin.
Presently, it can only be assumed how the rs3824410 SNP
might influence the susceptibility to asthma or the severity of
the disease. Investigating the possible function of this SNP with
the help of databases and bioinformatic tools shows that the
rs3824410 is in no close linkage with other frequent variations in
European populations, indicating that it might have an
independent role. The SNP might have a function because it
locates on a DNase hypersensitivity site in the lung, indicating an
open chromatin region. In addition, the SNP modifies the
binding sites of two transcription factors, namely CTCF and
interferon-stimulated gene factor 3 (ISGF-3) (Matys, 2006; Boyle
et al., 2012; Machiela and Chanock, 2015). Earlier, both
transcription factors have been found implicated in asthma
(Duerr et al., 2016; Schmiedel et al., 2016). Although the SNP
changes a less conserved nucleotide within the binding motifs
(see Supplementary Figure 2) it might have some influence on
the strength or time of the binding. It must be noted, that several
asthma susceptibility loci are known to contain CTCF motifs
(Pascoe et al., 2017).
The important role of the TEK gene and the Tie2 pathway in
asthma is further strengthened by the observation that the
expressions of 8 out of 10 selected genes on the Tie2 related
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leading to Th2-type allergic airway inflammation and
hyperresponsiveness (Figure 2). In the majority of the gene
expression studies of asthma, the expressions are measured only
at one point; in mice usually at the final stage when the airway
inflammation and AHR are already developed or in humans
when the patients experience no exacerbation. In the present
study, we measured the gene expression changes during the
process starting from the first airway inhalation of allergen until
the development of the Th2-type allergic airway inflammation at
three time points. Only the expression of Nfkb1 was significantly
elevated in all three occasions, which is not surprising, since
Nfkb1 codes the DNA binding subunit of the NFkB transcription
factor, which is a hub protein controlling a variety of processes,
including inflammation in the asthmatic lung (Liu et al., 2017).
Although, the Tie2 pathway is intensely investigated, the exact
role of the different participants of the pathway in different cells,
processes and diseases are far from clear (Brindle et al., 2006;
Augustin et al., 2009; Karar and Maity, 2011; Thurston and Daly,
2012; Souma et al., 2016; Zhang et al., 2019). The detailed
discussion of the significance of the expression changes of the
different genes is beyond the scope of this paper. We mention
here only decreased expressions of the Tek and Angpt1 genes
during the whole process. Tie2 which is coded by the TEK gene is
a tyrosine kinase receptor playing a central role in vascular
stability. Ang1 stimulates the activity of the kinase by binding
to Tie2 providing an anti‐inflammatory effect (e.g., inhibiting
NFkB1) and vessel stabilization (Saharinen et al., 2017). Lower
Tie2, together with the lower Ang1 expression can increase
inflammatory processes and weaken the barrier function of the
endothelial cells in the lung. Furthermore, the inflammatory
response to the inhaled allergen can also cause blood vessels to
dilate by becoming more permeable. It can be hypothesized that
these processes may contribute to the leakage of the activatedFrontiers in Genetics | www.frontiersin.org 8inflammatory cells into the surrounding tissues in the lung,
causing the characteristic symptoms of the allergic airway
inflammation. Our findings correlate with another study which
showed that Ang1 expression and Tie2 phosphorylation are
reduced in the lung of ovalbumin-treated mice (Simoes et al.,
2008). The study also suggested that Ang1 can protect against
airway inflammation and hyperresponsiveness in asthma.
In the stage I association study of allergic conjunctivitis, we
selected 5 SNP in the TEK gene with nominally significant p-
values. In conjunctivitis in stage II, we studied only children
because there were too few adult patients. Here, we found that
the genetic background of allergic conjunctivitis is different in
the two genders. The sex differences in allergic conjunctivitis is a
well-known phenomenon, especially in children (Chen et al.,
2008). This condition typically occurs more frequently in the
younger populations, between 4 and 12 years of age and more
frequently amongst boys. The rs622232 SNP was associated with
conjunctivitis only in boys in both allelic and dominant ways
with a relatively high odds ratio ((p = 0.004; OR = 4.76), while the
minor allele and the minor allele homozygotes of the SNP
rs7034505 were associated with an increased risk to
conjunctivitis in girls. Both SNPs are in introns and no
functions were attached to them in the public databases. The
rs622232 is in LD (r2 > 0.8) with rs621786 also without a known
function (Machiela and Chanock, 2015). The rs7034505 is in LD
with 4 SNPs, one of them (rs13293051) changes the binding site
of the transcription factor FOXP1 (Supplementary Figure 3),
which is a transcriptional repressor and is expressed in the retina
(FOXP1 Gene; Machiela and Chanock, 2015). No connection
between these SNPs and conjunctivitis was previously described.
It must be noted, however, that there are some weaknesses in
the study. We investigated several SNPs in different populations
and found SNPs associating with conjunctivitis and asthma, but
the associations were only nominally significant. If multiple testFIGURE 2 | LogFC values of the changes in gene expressions relative to controls. Only those genes are depicted whose expression showed at least one significant
change in their expressions during the process leading to Th2-type allergic airway inflammation and hyperresponsiveness in a mouse model of asthma. After
intraperitoneal sensitization with OVA on day 0 and 14 on days 28, 29, 30, and 31 mice were placed in a plastic chamber and challenged with OVA aerosol (in PBS)
or PBS only (controls) for 20 min by an ultrasonic nebulizer. On day 28, 30, and 31, 4 h after the allergen challenge, in groups 1, 2, and 3, respectively, mice were
anaesthetized, and the lungs were removed for gene expression analysis. The measurements were carried out by Agilent Whole Mouse Genome Oligo Microarray
4x44K chips. The results were deposited in GEO database with a record number of GSE11911 (GSE11911 - GEO DataSets - NCBI). *Indicates significant
differences.February 2020 | Volume 11 | Article 128
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the relative few patients, the associations would not have been
statistically significant. In contrast, in the gene expression study,
the p-values were adjusted, i.e., they were corrected for multiple
tests (see Supplementary Table 6). We think, however, that the
collected proofs that the TEK gene and its variations might have
a role in asthma are quite convincing. The functions of the Tie2,
the results of the gene expression in the animal model and the
association studies in independent populations strengthen each
other, providing accumulating evidence that TEK is a potential
gene in asthma pathogenesis. Although the supporting results are
fewer in conjunctivitis, there are several independent proofs
favoring this hypothesis as well. The gene is highly expressed
in the lungs, and it is also expressed in the eye. Mutations in the
TEK gene are associated with several eye diseases, and Tie2 is a
highly investigated target in different conditions such as
subretinal and choroidal neovascularization, macular oedema
or diabetic retinopathy (Campochiaro, 2015; Campochiaro and
Peters, 2016; Tan et al., 2017). Moreover, SNPs in the gene
showed suggestive associations with conjunctivitis in different
studies with high odds ratios (Fodor et al., 2018). The theoretical
mechanism leading to allergic conjunctivitis can be similar as it
was described in asthma. Naturally, in both cases, additional
studies in cell and tissue cultures, animal models and different
human populations are needed for more definitive proofs.
In conclusion, our results provide additional proof that the
Tie2 pathway, the TEK gene and its variations might have a role
in asthma and allergic conjunctivitis. The gene and its associated
pathways can be potential therapeutic targets in both diseases.DATA AVAILABILITY STATEMENT
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